Please login to the form below

Not currently logged in
PMLiVE Top Pharma List


Revenue 2017


The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Eylea was produced by Bayer.

Shaping healthcare

Shaping healthcare Or with our other big growth product Eylea, a VEGF treatment for the retina, we have 80, 000 patients under treatment as we speak.

Pharma sales help Bayer escape the worst from a bumpy 2017

Pharma sales help Bayer escape the worst from a bumpy 2017 Together they brought in just over 6.5bn, although Xarelto and Eylea accounted for over 80% of the total. ... Among them were a 7, 000 patient study of Xarelto in secondary stroke, a combination trial of Eylea and a drug-device combination for pneumonia.

The good, the bad and the ugly

The good, the bad and the ugly Bayer’s growth - a healthy 14.6% - was stimulated by a steady performance by Xarelto in Europe and Asia, and strong sales of its eye medicine Eylea in Japan, Europe and ... Regeneron remains the leading player, with 10% growth in 2017 thanks to

Regeneron and Bayer drop AMD combination

Regeneron and Bayer drop AMD combination Adding nesvacumab to Eylea did not however add enough additional benefit to warrant further development. ... Meanwhile, Novartis is making much of the fact that brolucizumab only needs to be dosed every 12 weeks, rather than every eight weeks for Eylea.

NICE first fast-track appraisal backs Bayer's Eylea

NICE first fast-track appraisal backs Bayer's Eylea The National Institute for Health and Care Excellence (NICE) has issued its first fast-track guidance, recommending Bayer’s Eylea (aflibercep) in choroidal neovascularisation (CNV). ... The final guidance on Eylea is due to be published on 1 November

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Subscribe to our email news alerts

Featured jobs


Add my company
Oxford PharmaGenesis

Oxford PharmaGenesis is an independently owned HealthScience communications consultancy, providing services to the healthcare industry, professional societies and patient groups....

Latest intelligence

Environment: where does the pharmaceutical industry stand?
The communication challenge of helping he next generation to be healthier
As the pressure on the health service increases the health of the next generation is vital for everyone. How do we show positive attitudes and change behaviour while future proofing...
Are we losing sight of what the democratisation of healthcare really looks like?
We have a core responsibility as healthcare communicators to consistently drive for better inclusion, engagement and compliance. What does the ‘democratisation of healthcare’ really look like?...